For Assistance Email: support@mentorhealth.com Phone: 800-385-1607 or Fax your PO to: 302-288-6884
Live Webinar
on
Why is Drug Induced Liver Injury an Important Mirror of Drug Safety and How to Spot this early
Date & Time: Tuesday, January 8, 2013
10:00 AM PST | 01:00 PM EST
Duration: 90 Minutes
Instructor: Charles H Pierce
Location: Online
Price : $195.00
Register Now
(for one participant)
Instructor Profile:
Overview: Ferreting out which Investigational Medicinal Products (IMP) might cause significant liver injury is not an easy process partly because there is confusion about how to test for liver injury and part because these AEs are rare (in the 1:10,000+ area) or "idiosyncratic" in type so are not picked up in the usual drug development process testing. We all know that AE's are one of the key ways the Clinical Investigator has of monitoring the safety of subjects or patients in her/his charge but some are very rare so the Investigators must be 'heads-up'. Add to this, the large number of "non-drug liver injuries, which easily confound the issue. To be forewarned is forearmed.
Areas Covered in the Session:
l
l l l l l l l
When is an abnormal lab value an AE? What are Liver Function Tests? Drug effects on the liver in perspective What are the risk and host factors for Drug Induced Liver Injury? Where does acetaminophen (Tylenol) toxicity fit in this process? How and when do we detect "rare" events? What are the types of the liver's response to drugs? How do 'non-drug liver injuries fit in the concept of DILI
Charles H Pierce Consultant, Clinical Research / Drug-Device Development Charles H. Pierce, MD, PhD, FCP, CPI is a consultant in the Clinical Research / Drug-Device Development arena specializing in bringing the message of GCP Regulations and Investigator Responsibility to the entire investigative team to help them understand the regulations as well as the ethics of research involving human subjects. Dr. Pierce serves as an advisor to several clinical research organizations, sits on industry based boards, and is VP of Medical Affairs for Harrison Clinical Research GmbH, a global CRO headquartered in Munich. He has been in the Clinical Research Industry for 20 years, has been involved in developing Phase I & IIa Clinical Pharmacology Units, Investigator and staff GCP training, and medical monitoring in both drug and device studies. ...more
Click here to register for this webinar Suggest a Topic
Who Will Benefit: l
More Webinars
Your Necessity is our Priority
The pharmaceutical and Biological Industry who sponsor preapproval clinical research and who are responsible for the outcome of the studies.
l l l l l l l l l
Principal Investigators and sub investigators Clinical Research Scientists Research Managers
Safety Nurses Clinical Research Associates (CRAs) and Coordinators (CRCs) Recruiting staff, QA / QC auditors and staff Study Monitors Clinical Research Data managers
It would be really nice if you can circulate this mail to all your deserving colleagues who can immensely benefit from this program. For more information, please contact the event coordinator. We look forward to seeing you at the webinar. Best regards, Event-coordinator MentorHealth About MentorHealth MentorHealth is a comprehensive training source for healthcare professionals. Our trainings are high on value, but not on cost. MentorHealth is the right training solution for healthcare professionals. With MentorHealth, healthcare professionals can make use of the best benefits relating to their professional training. MentorHealth www.mentorhealth.com Livermore Common, Fremont, CA 94539, USA Phone: 800-385-1607 or Fax your PO to: 302-288-6884
If you do not wish to receive this training alerts from MentorHealth Click Unsubscribe